Immunologic adverse reactions of β-blockers and the skin (Review)
Open Access
- 18 April 2019
- journal article
- review article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 18 (2) , 955-959
Abstract
β-Blockers are a widely utilised class of medication. They have been in use for a variety of systemic disorders including hypertension, heart failure and intention tremors. Their use in dermatology has garnered growing interest with the discovery of their therapeutic effects in the treatment of haemangiomas, their potential positive effects in wound healing, Kaposi sarcoma, melanoma and pyogenic granuloma, and, more recently, pemphigus. Since β-blockers are deployed in a variety of disorders, which have cutaneous co-morbidities such as psoriasis, their pertinence to dermatologists cannot be overstated. Likewise, β-blockers, like any other drug category, carry risks of side effects, some of which are dermatologic. These include triggering and exacerbation of psoriasis, psoriatic and rheumatoid arthritis, anaphylaxis, contact dermatitis, occupational contact dermatitis, Raynaud's disease, alopecia, lichen planus-like drug eruption, hyperhydrosis and vitiligo. While recent articles have focussed on the positive uses of β-blockers, it may also be wise to call our attention to the potential dermatologic adverse effects that may follow β-blocker use, as well as possible therapeutic approaches to these. This short review will focus on those dermatoses resulting from β-blocker use, which have an immunologic basis.Keywords
This publication has 66 references indexed in Scilit:
- The Effect of Beta‐Blockers on the Adaptive Immune System in Chronic Heart FailureCardiovascular Therapeutics, 2009
- β2 Adrenergic receptor on T lymphocytes and its clinical implicationsProgress in Natural Science: Materials International, 2009
- Psoriasiform dermatosesIndian Journal of Dermatology, Venereology and Leprology, 2008
- Beta Adrenergic Receptors in KeratinocytesDermatologic Clinics, 2007
- Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesionsJournal of Dermatological Science, 2000
- Sweating and Beta-Adrenoceptor AntagonistsDermatology, 1995
- Adverse Reactions with ??-Adrenoceptor Blocking Drugs An UpdateDrug Safety, 1993
- Alopecia possibly secondary to topical ophthalmic beta-blockers1990
- Is Mediation of Sweating Cholinergic, Adrenergic, or Both? A Comment on the LiteraturePsychophysiology, 1987
- Propranolol induced alopeciaAmerican Heart Journal, 1973